Aa
Aa
A
A
A
Close
Avatar universal

Progression After 1 Year Of Immunotherapy

What is the prognosis of someone with nsclc Stage 3 (adenocarcinoma) who went through 6 weeks of radiation and corresponding 6 weeks of chemo (carboplatin and taxol) without progression. His primary tumor at start was 7 cm x 6 cm. It shrunk to 5,7 cm x 5,7 cm at end of radiation and chemo. He was then placed on immunotherapy (Imfinzi) for 1 year with good results until now. He was off the Imfinzi for a year when progression occurred. His primary tumor went from 2.3 cm x 1.9 cm at PET scan on 7/2021 to 4.0 cm x 3.9 cm PET scan on 11/15. PET stated this is a 30% increase. They are going to rebiopsy it. What are they trying to accomplish by rebiopsy (with EBUS)? Please let us know his prognosis and reason for rebiopsy of primary tumor.  
0 Responses
Sort by: Helpful Oldest Newest
Have an Answer?

You are reading content posted in the Lung Cancer - Stage 3 Community

Didn't find the answer you were looking for?
Ask a question
Popular Resources
Here are 15 ways to help prevent lung cancer.
Tricks to help you quit for good.
Diet and digestion have more to do with cancer prevention than you may realize
How your health improves once you quit.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.